Mitral Valve and Tricuspid Valve disorders encompass a broad range of structural abnormalities that significantly influence cardiac function, hemodynamics and clinical outcomes. These atrioventricular valves work in close coordination, and dysfunction in one often affects the other due to shared annular mechanics, ventricular interactions and atrial remodeling. As interest in structural heart therapies continues to expand, clinicians and surgeons rely on specialised cardiology conference platforms to stay updated on evolving diagnostic strategies, repair techniques and innovative transcatheter interventions for both mitral and tricuspid pathologies.

Mitral and tricuspid valve diseases may be degenerative, functional or secondary to conditions such as atrial fibrillation, pulmonary hypertension and heart failure. The session explores pathophysiology including leaflet prolapse, flail segments, annular dilation, leaflet tethering, right ventricular dilation and atrial functional regurgitation. Echocardiography remains the cornerstone of diagnosis, with 3D imaging, strain analysis, CT structural mapping and MRI emerging as powerful adjuncts for anatomical and functional assessment.

The rise of interventional valve therapy has transformed management options, especially for high-risk surgical candidates. Edge-to-edge repair, annuloplasty devices, chordal systems and transcatheter mitral or tricuspid valve replacement platforms offer minimally invasive solutions with encouraging outcomes. Attendees will examine pre-procedure imaging workflows that define anatomical suitability, device favours and procedural risks, as well as the importance of fluoroscopic and echocardiographic fusion for optimal deployment.

Medical management remains significant in functional regurgitation driven by ventricular remodeling. Heart failure optimisation, guideline-directed therapy, management of pulmonary hypertension and rhythm control contribute to symptom reduction and may influence valve severity. Case discussions highlight how integrated care pathways combine medical therapy, advanced imaging and timely intervention to prevent irreversible chamber remodeling.

Participants will also explore postoperative and post-procedural considerations including anticoagulation strategies, device surveillance, imaging follow-up and long-term recurrence monitoring. The session highlights multidisciplinary team models involving surgeons, interventionalists, imaging specialists, anaesthetists and heart failure experts to guide personalised care for complex valve disease.

Future developments such as next-generation transcatheter valves, adaptable annuloplasty systems, AI-driven quantification, procedural simulation and improved imaging–device integration are shaping the trajectory of mitral and tricuspid interventions. With these innovations, clinicians can anticipate safer procedures, better durability and expanded treatment options for diverse patient populations.